RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $70 | -100.0% | 412,218 | -5.4% | 0.00% | – |
| Q3 2022 | $188,000 | -49.2% | 435,646 | 0.0% | 0.00% | – |
| Q2 2022 | $370,000 | -91.3% | 435,646 | -43.5% | 0.00% | -100.0% |
| Q1 2022 | $4,246,000 | -43.1% | 770,636 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $7,457,000 | -47.8% | 770,370 | -3.6% | 0.00% | -50.0% |
| Q3 2021 | $14,295,000 | -28.0% | 799,508 | -1.7% | 0.00% | -33.3% |
| Q2 2021 | $19,852,000 | +4.3% | 813,297 | +13.2% | 0.00% | 0.0% |
| Q1 2021 | $19,041,000 | +329.5% | 718,553 | +23.0% | 0.00% | +200.0% |
| Q4 2020 | $4,433,000 | +45.9% | 584,132 | -3.7% | 0.00% | 0.0% |
| Q3 2020 | $3,039,000 | -14.3% | 606,615 | +2.2% | 0.00% | 0.0% |
| Q2 2020 | $3,547,000 | +44.7% | 593,283 | +7.6% | 0.00% | 0.0% |
| Q1 2020 | $2,452,000 | -74.8% | 551,161 | -46.3% | 0.00% | 0.0% |
| Q4 2019 | $9,744,000 | +152.4% | 1,025,740 | +108.5% | 0.00% | 0.0% |
| Q3 2019 | $3,861,000 | -26.9% | 491,870 | +46.5% | 0.00% | 0.0% |
| Q2 2019 | $5,279,000 | -4.2% | 335,640 | +10.2% | 0.00% | 0.0% |
| Q1 2019 | $5,513,000 | -13.6% | 304,624 | -23.3% | 0.00% | 0.0% |
| Q4 2018 | $6,384,000 | +64.4% | 397,074 | +145.3% | 0.00% | 0.0% |
| Q3 2018 | $3,884,000 | – | 161,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |